BEAM-Modified Conditioning Therapy with Cisplatin+Dexamethasone Instead of Carmustine Prior to Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma

Ana Lucia Ron-Magaña; Omar Eduardo Fernandez-Vargas; Esperanza Barrera-Chairez; Carlos Silvestre Ron-Guerrero; Ana Jaqueline Bañuelos-Ávila

doi:10.12659/AOT.918259

22 October 2019 : Original article

BEAM-Modified Conditioning Therapy with Cisplatin+Dexamethasone Instead of Carmustine Prior to Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma

Ana Lucia Ron-Magaña^{ABCDEF 1,2}, Omar Eduardo Fernandez-Vargas^{CDEF 2,3}, Esperanza Barrera-Chairez^{ADF 2,3}, Carlos Silvestre Ron-Guerrero^{CDF 4}, Ana Jaqueline Bañuelos-Ávila^{ABCDEF 1*}

DOI: 10.12659/AOT.918259

Ann Transplant 2019; 24:584-587

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Back to the Article

BEAM-Modified Conditioning Therapy with Cisplatin+Dexamethasone Instead of Carmustine Prior to Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma

Your Privacy